RMD - ResMed cut at Oppenheimer after Eli Lilly's tirzepatide sleep apnea data
2024-06-25 13:37:45 ET
More on Eli Lilly, ResMed, etc.
- Eli Lilly: Throwing Its Weight Around - But, For How Long? (Technical Analysis)
- Eli Lilly: The Party Is Probably Nearing The End
- Eli Lilly And Alzheimer's Disease: The Paucity Of Progress
- Lilly gains approval of lebrikizumab in Canada for atopic dermatitis
- Eli Lilly collaborates with OpenAI for medicines against drug-resistant bacteria